Nasdaq Stocks

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today w

Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Expedia Group Inc (Symbol: EXPE), where a total of 25,950 contracts have traded so far, representing approximately 2.6 million underlying shares. That amounts to about

Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Netflix Inc (Symbol: NFLX), where a total volume of 123,047 contracts has been traded thus far today, a contract volume which is representative of approximately

Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Apple Inc (Symbol: AAPL), where a total volume of 374,680 contracts has been traded thus far today, a contract volume which is representative of approximately 3

Nasdaq NDAQ is well-poised for growth based on organic initiatives, strategic buyouts, and solid capital position.Shares of Nasdaq have gained 4.6% year to date against the industry's decline of 0.7%. The Zacks S&P 500 composite has risen 11.1% in the said time frame. The Za

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all.

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth stock that can live up to its true potential can be a tough task.

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth stock that can live up to its true potential can be a tough task.

Deciphera Pharmaceuticals, Inc. DCPH announced that the FDA has approved its kinase inhibitor Qinlock (ripretinib) for treating patients with advanced gastrointestinal stromal tumors (GIST) who were already treated with three or more kinase inhibitors including Novartis’ NVS G

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to disco

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, gr

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, gr

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

Investors focused on the Medical space have likely heard of Calithera Biosciences (CALA), but is the stock performing well in comparison to the rest of its sector peers? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector shou

Investors focused on the Computer and Technology space have likely heard of Cadence Design Systems (CDNS), but is the stock performing well in comparison to the rest of its sector peers? Let's take a closer look at the stock's year-to-date performance to find out.

Here are three stocks with buy rank and strong income characteristics for investors to consider today, May 18th:

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 18th:         

India's $266 billion economic rescue package rests mostly on boosting company credit but contains scant new public spending, tax breaks or cash support to revive demand and prevent firms from collapsing, business leaders and economists say.

By Michael Foster Has this market gone too far, too fast? Is another crash coming? And what the heck should we be buying now?

The coronavirus pandemic seems to have brought the U.S manufacturing sector to a standstill.  Per the Federal Reserve, industrial production slumped 11.2% in April — the worst drop in the 101-year history of the index, as several factories had to slowdown or suspend operation